IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 1 filers reported holding IBERE PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $495 | – | 49,023 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integrity Capital Management (HK) Ltd | 46,717 | $454,000 | 1.44% |
| Lynwood Capital Management Inc. | 51,401 | $515,000 | 0.49% |
| TEGEAN CAPITAL MANAGEMENT, LLC | 91,422 | $888,000 | 0.46% |
| HRS Investment Holdings, LLC | 112,050 | $1,087,000 | 0.36% |
| DARK FOREST CAPITAL MANAGEMENT LP | 96,740 | $940,000 | 0.35% |
| BASSO CAPITAL MANAGEMENT, L.P. | 170,114 | $1,654,000 | 0.18% |
| SPRING CREEK CAPITAL LLC | 400,000 | $3,880,000 | 0.15% |
| Vestcor Inc | 400,000 | $3,880,000 | 0.14% |
| Castle Creek Arbitrage, LLC | 253,446 | $2,458,000 | 0.12% |
| Knott David M Jr | 36,000 | $348,000 | 0.12% |